Lululemon Stock Is a Buy After CEO Exit

Lululemon reported Q3 revenue up 7% year-over-year and overall comps up 1%, but the Americas business weakened materially with comparable sales down 5% (a 2% revenue decline) and EPS falling 10% as costs rose; CEO Calvin McDonald will step down Jan. 31 (staying on as advisor through March) with CFO Meghan Frank and CCO André Maestrini as interim co-CEOs while a search for a permanent successor is underway. Management admits product assortment became stale and has launched October initiatives to boost new-style penetration to 35% next spring and cut product development cycles from 18–24 months to 12–14 months, but these moves came after weakness surfaced early in 2024 and LULU stock has fallen roughly 60% since then. Lululemon expects 2025 EPS of $12.92–$13.02 (tariffs cited as a headwind); investors should note the company’s strong brand and international growth, but meaningful Americas recovery likely won’t show until mid-2026 with a potential 2027 rebound if a new CEO accelerates the turnaround—shares trade under 16x current EPS estimates, implying upside if execution succeeds.

Analysis

Lululemon reported third-quarter revenue growth of 7% year-over-year and a 1% comp increase overall, but the Americas underperformed with comparable sales down 5% and a 2% regional revenue decline; earnings per share fell 10% as costs rose faster than revenue and shares have lost roughly 60% since early 2024. International markets drove the improvement, while management concedes the U.S. assortment became stale and corrective actions announced in October arrived late relative to the timing of the weakness.

CEO Calvin McDonald will step down on Jan. 31 and remain as a senior advisor through March, with CFO Meghan Frank and CCO André Maestrini serving as interim co-CEOs while the company searches for a permanent successor; leadership transition timing is therefore a near-term governance risk. The operational plan targets raising new-style penetration to 35% by next spring and shortening product development cycles from 18–24 months to 12–14 months, initiatives that should help but will not materially benefit Americas results until at least mid-2026.

Lululemon guides 2025 EPS of $12.92–$13.02 and currently trades below 16x that range, implying upside if product execution, margin recovery and tariff pressure are resolved; however meaningful recovery appears contingent on successful CEO appointment, faster product cadence, and execution against merchandising and cost control targets, with a potential 2027 rebound if those elements align. Key risks are persistent tariff-driven margin headwinds, execution delay on product cycles, and continued competitive pressure in the Americas.

Key Decisions for Investors

• Consider a selective, patient accumulation only if you have a multi-year horizon — valuation below 16x 2025 EPS and a strong brand make LULU an asymmetric turnaround candidate, but expect no material Americas recovery before mid-2026
• Defer sizeable new buys until two operational/corporate catalysts are visible: appointment of a permanent CEO with a credible merchandising turnaround and clear metrics showing faster product-cycle timing and rising new-style penetration toward 35%
• Use position sizing or hedges to limit near-term downside given tariff headwinds and cost pressure, and consider trimming exposure if sequential Americas comps or margins deteriorate further
• Monitor quarterly updates for signs of stabilization in Americas comps, progress on the 12–14 month development target, and any guidance revisions on tariffs — accelerate buying only on concrete, sustained improvement in these indicators